What Counts as Risk in the Deal Room?
The subject here is the content of the risk shift associated with QSBS: which characteristics of a startup and which structures of a financing round change when VC funds become more willing to cross their investment threshold. The useful task is to separate risk into mechanisms—uncertain development, financial fragility, monitoring difficulty, unfamiliarity, missing validation, and reduced risk sharing—rather than treat it as one invisible score. That lets readers interpret the study's percentages as evidence about particular deal choices, not as a claim that every dimension of startup risk moved in the same way.
The comparison is also specifically about VC funds. After the reform, the paper reports selection changes for VCs in eligible sectors relative to its comparison groups, while angels and corporate investors do not show statistically significant comparable shifts on these dimensions. The contrast is consistent with the organizational mechanism already established: the tax benefit reaches an investor whose payoff is tied to a convex upside, and that investor changes the type of uncertainty they are prepared to accept.
Risk is a bundle of exposures, not one number
A startup can be risky because nobody knows whether its product will work, because its cash obligations are difficult to meet, because the investor cannot monitor it closely, or because there is little independent evidence that the company deserves funding. These exposures can coexist, but they are not identical. A pre-commercial company presents a problem of technical and commercial uncertainty. A debt-carrying company presents a problem of fixed obligations and reduced flexibility. A distant or unfamiliar investment presents a problem of information and oversight.
This distinction matters for the interpretation of selection evidence. If a VC fund invests earlier in a company's development, that does not necessarily mean the fund has accepted more leverage. If it invests across a state line, that does not necessarily mean the technology is less viable. Each choice changes a different interface between the fund and the company. The paper uses several such choices together because no single observable feature captures the whole distribution of possible startup outcomes.
The measures also concern the decision at entry. They ask what the fund accepts when it supplies initial capital, before the company has generated the later valuation or failure outcome. That temporal separation is important. A later failure may be consistent with a riskier initial choice, but the failure itself cannot define what the investor knew or accepted at the time. The selection variables are therefore mechanisms linking the tax incentive to the portfolio, not retrospective labels attached to every unsuccessful company.
Earlier stage and debt expose the fund to different uncertainty
The strongest selection changes concern a company's stage and capital structure. After the QSBS reform, VC investments in eligible sectors become 74 percent more likely to occur in pre-commercial-stage startups and 157 percent more likely to involve firms with pre-existing debt. These are relative changes in the study's specified comparisons, not percentage-point probabilities for the entire market. Their importance lies in the different risks they represent.
A pre-commercial startup has not yet demonstrated commercial viability in the ordinary sense. Its technology may still be in development, its product may be untested, and its route to revenue or an exit may be long. Information asymmetry is high: founders know more about the technical state of the project than outside investors, while investors must decide whether the possibility of a breakthrough compensates for the lack of a proven market. Funding such a company moves the fund toward the uncertain end of the development lifecycle.
Debt changes the downside in another direction. A young company with pre-existing obligations must make payments or negotiate with creditors while its cash flows remain uncertain. Those fixed claims can make a downturn more damaging and can constrain the company's ability to use new financing for experimentation or growth. The investor is not merely accepting uncertainty about demand or technology; the investor is accepting a capital structure that may amplify bad news.